Lemoine A - Search Results

1

No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC.

Grandal B, Aljehani A, Dumas E, Daoud E, Jochum F, Gougis P, Hotton J, Lemoine A, Michel S, Laas E, Laé M, Pierga JY, Alaoui Ismaili K, Lerebours F, Reyal F, Hamy AS. Grandal B, et al. Among authors: lemoine a. Cancers (Basel). 2022 Jun 23;14(13):3080. doi: 10.3390/cancers14133080. Cancers (Basel). 2022. PMID: 35804852 Free PMC article.

2

Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.

Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, Wang Y, Abdennebi I, Labrosse J, Sautter C, Toussaint A, Sablone L, Laas E, Khallouch S, Coussy F, Santulli P, Chapron C, Bobrie A, Jacot W, Sella N, Dumas E, Sénéchal-Davin C, Espie M, Giacchetti S, Maitrot L, Plu-Bureau G, Coutant C, Guerin J, Asselain B, Fumoleau P, Rodrigues M, Decanter C, Mailliez A, Delrieu L, Lemoine A, Jouannaud C, Houdre D, Reyal F, Hamy AS; Seintinelles Research Network. Mangiardi-Veltin M, et al. Among authors: lemoine a. Reprod Biomed Online. 2022 Jun;44(6):1031-1044. doi: 10.1016/j.rbmo.2021.12.019. Epub 2022 Jan 19. Reprod Biomed Online. 2022. PMID: 35525718

3

Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study.

Lemoine A, Perrier M, Mazza C, Quinquenel A, Brasseur M, Delmer A, Vallerand H, Dewolf M, Bertin E, Barbe C, Botsen D, Bouché O. Lemoine A, et al. Cancers (Basel). 2022 Apr 14;14(8):1993. doi: 10.3390/cancers14081993. Cancers (Basel). 2022. PMID: 35454896 Free PMC article.

4

[Evaluation of the feasibility of a program of adapted physical activity in day hospital of digestive oncology: From the point of view of patients].

Crespel C, Brami C, de Boissieu P, Mazza C, Chauvet K, Lemoine A, Gavlak B, Léandri C, Brasseur M, Bertin E, Bouché O. Crespel C, et al. Among authors: lemoine a. Bull Cancer. 2018 Mar;105(3):228-233. doi: 10.1016/j.bulcan.2017.11.011. Epub 2018 Feb 6. Bull Cancer. 2018. PMID: 29426740 French.

5

Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.

Garofalo A, Farce A, Ravez S, Lemoine A, Six P, Chavatte P, Goossens L, Depreux P. Garofalo A, et al. Among authors: lemoine a. J Med Chem. 2012 Feb 9;55(3):1189-204. doi: 10.1021/jm2013453. Epub 2012 Jan 25. J Med Chem. 2012. PMID: 22229669

6

Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives.

Garofalo A, Goossens L, Baldeyrou B, Lemoine A, Ravez S, Six P, David-Cordonnier MH, Bonte JP, Depreux P, Lansiaux A, Goossens JF. Garofalo A, et al. Among authors: lemoine a. J Med Chem. 2010 Nov 25;53(22):8089-103. doi: 10.1021/jm1009605. Epub 2010 Oct 29. J Med Chem. 2010. PMID: 21033670

7

Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.

Wlodarczyk N, Le Broc-Ryckewaert D, Gilleron P, Lemoine A, Farce A, Chavatte P, Dubois J, Pommery N, Hénichart JP, Furman C, Millet R. Wlodarczyk N, et al. Among authors: lemoine a. J Med Chem. 2011 Mar 10;54(5):1178-90. doi: 10.1021/jm101067y. Epub 2011 Feb 7. J Med Chem. 2011. PMID: 21299244

8

Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors.

Garofalo A, Goossens L, Six P, Lemoine A, Ravez S, Farce A, Depreux P. Garofalo A, et al. Among authors: lemoine a. Bioorg Med Chem Lett. 2011 Apr 1;21(7):2106-12. doi: 10.1016/j.bmcl.2011.01.137. Epub 2011 Feb 3. Bioorg Med Chem Lett. 2011. PMID: 21353546

9

Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.

Verones V, Flouquet N, Lecoeur M, Lemoine A, Farce A, Baldeyrou B, Mahieu C, Wattez N, Lansiaux A, Goossens JF, Berthelot P, Lebegue N. Verones V, et al. Among authors: lemoine a. Eur J Med Chem. 2013 Jan;59:39-47. doi: 10.1016/j.ejmech.2012.10.051. Epub 2012 Nov 8. Eur J Med Chem. 2013. PMID: 23202849

10

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

Tourteau A, Andrzejak V, Body-Malapel M, Lemaire L, Lemoine A, Mansouri R, Djouina M, Renault N, El Bakali J, Desreumaux P, Muccioli GG, Lambert DM, Chavatte P, Rigo B, Leleu-Chavain N, Millet R. Tourteau A, et al. Among authors: lemoine a. Bioorg Med Chem. 2013 Sep 1;21(17):5383-94. doi: 10.1016/j.bmc.2013.06.010. Epub 2013 Jun 15. Bioorg Med Chem. 2013. PMID: 23849204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page